A802715 is used as a cytotoxic agent against human melanoma (Be11 and MeWo) and human squamous cell carcinoma (4197 and 4451) cell lines; it enhances radiation-induced suppression of S-phase entry in p53 wild-type cells and modulates G2/M cell cycle arrest depending on p53 status.